Investor Relations

With effect from 15 February 2016 the businesses of Al Noor Hospitals Group plc (“Al Noor”) and Mediclinic International Limited (“Mediclinic”) were combined by way of a reverse takeover by Al Noor of Mediclinic (“the Combination”). The Combination was effected by way of a scheme of arrangement under the South African Companies Act under which Mediclinic shareholders received 0.62500 new Al Noor shares for each Mediclinic share held as at the scheme record date. The company name of Al Noor will change to Mediclinic International plc on or about 15 February 2016 and the enlarged group will have a premium listing on the Main Market of the London Stock Exchange (share code: ANH), as well as an inward secondary listing on the Main Board of the Johannesburg Stock Exchange (share code: MEI).

Please visit the website of Mediclinic for further Investor Relations information.